VENLO, Netherlands--(BUSINESS WIRE)--QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced a significant increase in the powerful capabilities of its QIAcuity Digital PCR (dPCR) system ...
Performance and side effect evaluation of sequentially reduced radiotherapy doses in a phase II trial of induction chemotherapy (IndCT) followed by concomitant chemoradiotherapy (CTX) for advanced ...
The predicted potential of quantitative t cell repertoire analysis using next-generation sequencing in anti-PD-L1 treatment in NSCLC patients. This is an ASCO Meeting Abstract from the 2018 ASCO ...
PCR is a technique used to amplify target DNA in a sample. It’s a well-known method that has undergone numerous modifications to enhance its capabilities. This year, it’s turning 40 years old. PCR has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results